Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
Clinical trial NCT00585689 · COMPLETED
Trial details
- NCT number
- NCT00585689
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2013-04-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.